Global Ophthalmoscope Market Outlook to 2027

company logo

Dublin, July 07, 2022 (GLOBE NEWSWIRE) — The “Ophthalmoscope Market – Global Outlook and Forecast 2022-2027” report has been added to from offer.

Ophthalmoscope (fundoscopy) is a medical device used to perform ophthalmoscopy to understand the health of the vitreous humor, optic disc and retina of the eye. Thus, ophthalmoscopy is the most vital part of eye examination and is used to detect symptoms of retinal vascular diseases such as cataracts, glaucoma, diabetic retinopathy and macular degeneration of age. These are eye examinations for patients with diabetes mellitus in which ophthalmoscopy plays a vital role in routine monitoring of diabetic retinopathy status.

The increasing prevalence of eye diseases is driving the growth of the eye testing equipment market. Approximately 596 million people suffer from distance vision impairment worldwide, including 43 million who are blind. About 510 million patients, on the other hand, had uncorrected near visual impairment. Most of these populations live in low- and middle-income countries, accounting for 90% of cases. About 895 million people will be visually impaired from afar by 2050, and 61 million will be blind. The growing target population provides high growth opportunities for players.

The following factors are likely to contribute to the growth of the global ophthalmoscope market over the forecast period:

  • Raising awareness among the patient population by increasing eye care services in developed countries

  • Increased prevalence of eye disorders and surgical procedures

  • Increasing prevalence of eye disorders Patient population

  • Increased government initiative for eye care

Market trends

Technological innovations and advanced products will further optimize the use of ophthalmoscope devices in the industry. Scanning laser ophthalmoscopes have been on the market since the 1990s, but the growing popularity and the provision of many benefits have recently given the industry a new direction. Currently, scanning laser ophthalmoscopes have improved considerably. These ophthalmoscopes can obtain images with wider fundus views while maintaining high resolution and increasing application rate during eye exams. These are superior to conventional fundoscopy with their ability to visualize abnormal changes in the choroid and retina.

On the other hand, indirect laser ophthalmoscopy, smartphone-based indirect ophthalmoscope and vision enhancement technology are innovations that are revolutionizing the industry. Also, the growing application of ophthalmoscopes in other medical fields such as neurology and headache treatment will create new opportunities in the coming times.

Vendor analysis

  • In 2021, Heine launched a new indirect ophthalmoscope with the product Omega600. By introducing new products, the company has brought significant change to the market with vision enhancement technology to increase illumination and increase the clinician’s ability to test the patient’s cataract status and vitreous opacities. .

  • In 2021, the BMJ Journal reported that smartphone ophthalmoscopy technology has a potential route in the era of covid-19 for non-ophthalmic medicine. The smartphone ophthalmoscope generally performed more favorably than direct hands-on time. This device gives practitioners the ability to work from a long distance to examine and visualize the fundus at arm’s length compared to the general ophthalmoscope.

  • In 2021, the Hillrom company introduced the Welch Allyn PanOptic Plus ophthalmoscope devices which provide a 20 times larger viewing area.

Market factors

Increased efforts by manufacturers to promote awareness of developments in ophthalmoscope technology are driving the expansion of the global ophthalmoscope market. In addition, rising healthcare expenditures for the treatment of vision loss, blindness and sight-threatening disorders are expected to drive demand for primary eye care and examinations, thereby increasing demand for essential equipment such than ophthalmoscopes during the forecast period.

On the other hand, the increasing prevalence of eye diseases influences the need for eye examination and leads to the strong growth of the applications of ophthalmoscopes. Cataracts, glaucoma, diabetic retinopathy and age-related macular degeneration are the main eye conditions requiring ophthalmoscopes.

The increasing prevalence of the above conditions and excellent access to eye care services in developed countries has positively triggered the rate of usage of ophthalmoscopes. The increasing prevalence has led to eye examination and its demand for ophthalmoscopy for diabetic retinopathy, cataracts, glaucoma, corneal opacities and other eye conditions.

Answers to key questions:
1. What is the market size for ophthalmoscopes?
2. What are the latest trends in the ophthalmoscope market?
3. Who are the Key Players of the Ophthalmoscopes Market?
4. What are the growth catalysts in the Ophthalmoscopes market?
5. Which end-user segment will hold the largest ophthalmoscope market share by 2027?

Main topics covered:

1 Research methodology

2 research objectives

3 Research process

4 Scope and coverage
4.1 Market Definition
4.2 Base year
4.3 Scope of the study

5 Report assumptions and caveats
5.1 Main caveats
5.2 Currency conversion
5.3 Market Derivation

6 The market at a glance

7 Presentation
7.1 Overview

8 Market Opportunities and Trends
8.1 Technological Advancements and New Applications of Ophthalmoscopes
8.2 Government eye care initiatives
8.3 Higher Growth Opportunities in Emerging Markets

9 Market Growth Catalysts
9.1 Rise in Awareness of Eye Care Services in Developed Countries
9.2 Increased prevalence of eye disorders and surgical procedures
9.3 Advent of advanced ophthalmoscopes
9.4 Increase in the population of patients with eye disorders

10 Market Restrictions
10.1 Lack of Eye Care Services in Emerging Markets
10.2 Shortage of ophthalmologists in developing countries
10.3 Strict regulations and product recalls

11 Market landscape
11.1 Market Overview
11.2 Market Size and Forecast
11.3 Five forces analysis

12 types
12.1 Market Overview and Growth Driver
12.2 Market Overview
12.3 Direct ophthalmoscope
12.4 Indirect ophthalmoscope

13 Display
13.1 Market Overview and Growth Driver
13.2 Market Overview
13.3 Glaucoma
13.4 Diabetic retinopathy
13.5 Age-related macular degeneration
13.6 Retinal detachment
13.7 Others

14 End user
14.1 Market Overview and Growth Driver
14.2 Market Overview
14.3 Eye clinics and hospitals
14.4 Ophthalmologists and Optometrists
14.5 Ambulatory surgery centers

15 Geography
15.1 Market Overview and Growth Driver
15.2 Geographic overview

16 North America
16.1 Market Overview
16.2 Market Size and Forecast
16.3 Typology
16.4 Display
16.5 End User
16.6 Key countries

17 Europe
17.1 Market Overview
17.2 Market Size and Forecast
17.3 Typology
17.4 Display
17.5 End User
17.6 Key countries

18 years old
18.1 Market Overview
18.2 Market Size and Forecast
18.3 Typology
18.4 Display
18.5 End User
18.6 Key countries

19 Latin America
19.1 Market Overview
19.2 Market Size and Forecast
19.3 Typology
19.4 Display
19.5 End User
19.6 Key countries

20. Middle East and Africa
20.1 Market Overview
20.2 Market Size and Forecast
20.3 Typology
20.4 Notice
20.5 End User
20.6 Key countries

21. Competitive Landscape
21.1 Competition Overview
21.2 Market Share Analysis

22. Key Company Profiles
22.1 Heine
22.2 Dino-Lite Europe (Anmo Electronics Corporation)
22.3 Iridex
22.4 Halma
22.5 Nidek
22.6 Oscar Boscarol
22.7 Rodolphe Riester
22.8 Welch Allyn (Hill Rom)

23. Other Important Suppliers
23.1 Albert Waeschle
23.2 American Diagnostic Society
23.3 Shanghai Bolan Optical Electrical
23.4 Carl Zeiss
23.5 Lumibird Group (Ellex)
23.6 Essilor International (Essilor Instruments USA)
23.7 Heidelberg Engineering
23.8 Invotech Excel
23.9 Medline Industries
23.10 Neitz Instruments
23.11 Suzhou Kangjie Medical
23.12 Spengler Holtex Group
23.13 Top con
23.14 Lumenis
23.15 Zumax Medical Co.Ltd
23.16 66 Vision Tech
23.17 Zhejiang Honsun Medical Technologies Co.Ltd

24. Report Summary
24.1 Key Points to Remember
24.2 Strategic Recommendations

25. Quantitative Summary
25.1 Geography
25.2 Typology
25.3 Display
25.4 End User
25.5 Type (geographic distribution)
25.6 Indication (geographic distribution)
25.7 End user (geographic distribution)

26. Appendix

For more information on this report, visit

CONTACT: CONTACT: Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Comments are closed.